Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Completed · Phase 3
Conditions studied: Turner Syndrome, Hypogonadism, Premature Ovarian Failure
In brief
The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls who are very short and whose ovaries do not work. We will examine changes bone, protein and fat metabolism under the influence of estrogen delivered by a patch trough the skin vs estrogen taken orally. These studies are conducted while the girls are taking GH therapy.
Key facts
- Study ID
- NCT00140998
- Run by
- Nemours Children's Clinic
- People needed
- 16
- Starts
- 2001-01-01
- Expected to finish
- 2004-06-01
- Last updated by the study team
- 2017-11-30
Who can join
Age: 10 and older, up to 16. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Nemours Children's Clinic — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.